Chu Shelley 4

What Happened

Shelley Chu, a director of Odyssey Therapeutics (ODTX), purchased 11,111 shares on 2026-05-11 at $18.00 per share, for a total purchase price of $199,998. The filing reports this as a purchase (code P) and the footnote states these shares were purchased in the issuer's initial public offering.

Key Details

• Transaction date: 2026-05-11
• Transaction type: Purchase (P) — open market or private purchase per Form 4
• Price and amount: 11,111 shares at $18.00 each; total $199,998
• Footnote: F1 — reflects shares purchased in the issuer's initial public offering (IPO)
• Shares owned after transaction: Not specified in the provided filing summary
• Filing timeliness: Reported on 2026-05-11 (same day as the transaction date), indicating a timely filing

Context

Purchases by directors are often of interest to investors because they represent an insider acquiring stock, but filings do not state the insider’s motivation. In this case, the shares were acquired through the company’s IPO allocation rather than as a secondary-market open-market buy, which is common for director IPO participation.